An observational study in Aortic Aneurysm, Thoracic, sponsored by Nicolaus Copernicus University. Status unknown at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-03-24.
Sponsored by Nicolaus Copernicus University · Observational
Minimally invasive aortic valve (AV) surgery has become widely accepted alternative to standard sternotomy. Despite possible reduction in morbidity, this approach is not routinely performed for aortic surgery. Evidence exists, however, on safety of this approach together with promising results regarding its long-term durability. The MIRAGE Registry is aimed to collect and analyse the data from multiple aortic excellence centres and to analyse them in numerous clinical scenarios.
960 studies on the registry are indexed under Aneurysm; 175 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 151 across 443 observational studies indexed under Aneurysm.
Browse Aneurysm studies →Nicolaus Copernicus University is the lead sponsor of 19 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients undergoing minimally-invasive aortic root and aorta surgery.
Exclusion Criteria:
Procedure: Aortic Root Surgery
Procedure: Aortic Root Surgery
Procedure: Aortic Root Surgery
First time, isolated, minimally invasive (mini-sternotomy, RALT) aortic root or aorta surgery
Also known as: Ascending Aorta Aneurysm Surgery, Aortoplasty, Supracoronary Replacement
Early (in-hospital/30-day) mortality
Time frame: 30 days
Freedom from reoperation
Time frame: 5 years
Long-term mortality
Time frame: 5 years
Plan to share: Undecided
This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nicolaus Copernicus University